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Survival is a function of the ability of an
organism to fill its ecological niche efficiently and
to defend itself against aggression.

The evolution

from unicellular through ollgocellular to multicellular
forms with highly differentiated organ systems involves
many obvious advantages.
ages.

But there are also disadvant¬

Multicellular organisms may be hosts for uni¬

cellular and subcellular pathogens;

moreover,

the

processes of rapid proliferation and extensive different¬
iation create increased opportunities for somatic
mutation and the development of uncontrolled neoplastic
cell lines.
unproven,

It is teleologically reasonable,

albeit

that defenses should develop to meet these

challenges.
In 1882 Metchnikoff proposed that phagocytic
cells provided significant protection against microbial
infections. He showed that phagocytosis is an important
defense in a wide range of species -- from amoeba and
colonial protozoa where phagocytic and digestive functions
are combined,

through higher forms in which wandering

cells can be mobilized for use in any part of the
organism

(Humphrey & White,

1970).

Metchnikoff's theory

was strongly attacked by those who stressed the contri¬
bution of specific humoral defense factors.
reasons,

For many

including methodological difficulties,

specific

cell-mediated defenses were only slowly appreciated.

In

1891

Koch described the delayed time

reaction * elicited by an intradermal
in a sensitized host.
mononuclear cell

tuberculin test

In following years

infiltrate

lesions was noted

course of a skin

characteristic of

(reviewed by Uhr,

in 19^2 showed that while

the perivascular

1966).

Landsteiner

serum alone could not

the ability to produce a delayed skin test,
exudate cell could.
established that

Further work by

transfer

peritoneal

Chase and others

lymphoid cells were the necessary and

effective component of such an
(Bloom & Chase,

these

196?).

"adoptive transfer"

Landsteiner also developed

"artificial antigens" — well-defined small molecules
(haptens)

attached to proteins

(carriers).

Using

these he demonstrated that humoral antibody of marked
hapten specificity
In contrast,
display

could be elicited

(Landsteiner,

delayed hypersensitivity was

carrier specificity

course and the histology of

shown to

(Benacerraf & Gell,

These four characteristics

—

19^5)*

1959).

the delayed time

the in vivo reaction,

transferability by living lymphoid cells but not by
serum,
basic

and carrier specificity

-- have remained the

criteria for defining delayed hypersensitivity.

Classical

tubercular hypersensitivity and contact allergy

are now considered two examples

of

cell-mediated

immunological reactions;

others

include

intracellular parasites,

homograft rejection and

immunity to

- 3 -

tumor rejection.

The operative cells belong to a sub¬

population of lymphocytes dependent on the presence of
the thymus and referred to as T-lymphocytes.

The other

functionally defined population of cells is called
B-lymphocytes.

These differentiate,

proliferate and

mature into plasma cells which synthesize humoral
antibody.
Specifically sensitized T cells are directly
cytotoxic for target cells and when exposed to antigen,
they release soluble factors which effect vascular
permeability,
(Roitt,

macrophage activity and other lymphocytes

1969).

These responses seem to be the mechanism

for the observed in vivo phenomena and have become the
basis for a host of in vitro assays.

In addition,

T cells

may cooperate with precursors of antibody-producing cells
during the immune response to certain antigens

("helper"

cell function).
In clinical and experimental situations where
the thymus is congenitally absent,

there is a defect

in the ability of the organism to mount an immune response.
Homografts are not rejected,

contact sensitization

cannot be achieved and humoral antibody reponse to a
variety of protein antigens is diminished. Patients with
such defects are highly vulnerable to opportunistic viral
and fungal infections and the natural history of the

-

disease

4 -

is brief and fatal.

logically,

Clinically and immune-

depletion of cell-mediated immunity

(CMI)

is

a much graver defect than absence of humoral antibody
(Fudenberg et al»

1971).

associated with CMI,

The

class

the T cells,

of lymphocytes
seem intimately

related to the capacity for organizing an immune response,
particularly to proteins,

which are apparently

the most

relevant naturally-occurring antigens.
The clonal
postulates

selection theory

of

immunology

that immunocompetent lymphocytes are pre¬

committed to respond to specific antigens.

It seems

likely

that the

initiation of cellular activity for an immune

response

is mediated by the

specific

cellular receptors.

interaction of antigen with
However,

the receptors

for T-lymphocytes are only poorly characterized
structural or functional

in

terms.

One approach to the study of T-cell receptors
is through affinity labelling,
been very useful
sites

(Singer,

ability

in the study

196?).

a technique which has
of antibody

combining

The method depends upon the

of a bifunctional

reagent

to

(1)

combine

specifically with the particular antibody,
readily with amino acid residues
Hill

(1971)

and

(2)

react

to form covalent bonds.

reported that a hapten-derived affinity label

could interfere with T-cell

function and could permit

-

5
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the isolation of a putative receptor.

The first part of

this

that system.

study is an attempt

to reproduce

Whereas humoral antibody
cellular immunity

can be hapten specific,

consistently shows

It would be useful

to have a system which would

facilitate more careful
of T-cell function.

investigation of this

The relevant

however,
cell

a

could be used to study the specificity

of

this study

the basis

Thus,

involved the synthesis

sequence polypeptide antigen.

of the

for immunogenicity.

such an antigen could serve as

"carrier-derived" affinity label.

part

cannot be precisely

A defined sequence polypeptide antigen,

receptor and the requirements

Further,

requirement

"carrier" determinants

of classical hapten-protein antigens
identified.

"carrier specificity".

of

the second
of a defined

Materials,

Methods and Results
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I.

Efforts to Synthesize a Hapten-Derived Affinity Label
(after Hill, 1971)

Materials.
6-2,4-dinitrophenyl-L-lysine
gift of Dr.
of Porter,

William Konigsberg
1950).

solution" was:
(1.68g,

20mmol)

& Ward,

1945).

(DWP-lysine) was a

(prepared by the method

Na2S was stored at 4°C.

Na2S*9H20
in H20

(4.8g,

2Qmmol) plus NaHCOo

(10ml) at 40° C

Reduction of DNP-lysine

The "reducing

(after Hodgson

(after Hodgson & Ward,

£-DNP-L-lysine HC1

(348.5mg»

was dissolved in methanol
wise addition of ION NaOH,

(10ml),

Immol)

1945)*

(I in Fig.

1)

neutralized by drop-

and warmed to 55°0.

The

reducing solution was added dropwise until in excess
as detected by ferrous sulfate paper.

The solution was

then cooled to 0° and the precipitate filtered and
recrystallized from ethanol.

The clean tan crystals

were shown to have one nitro group reduced to an amino
group

(see below).

Which group was reduced is unclear,

but could probably be established by NMR studies.
product is called £-2,4-(nitro,
(NAP-lysine)

(II).

The

amino) phenyl-L-lysine

I?

Figure 1
Dinitrophenyl Derivatives

I

1-fluoro-2,4-dinitrobenzene

DNFB
F

II

III

IV

V

£-2,4-dinitrophenyl-lysine

£-DNP-lysine

m-nitrobenzenediazonium
fluoroborate

m-NBDF

£-2-nitro-4-aminopheny1-lysine

£-NAP-lysine

£-2-nitro-4-diazophenyl-lysine

£-NDP-lysine
fJH

HLfO-CH-CO0 H

7

Evidence for Formation of NAP-lysine.
(1)

Electrophoresis.

diagrammed in Fig.

2).

(Conditions given and results
The results indicate the presence

of an additional positively charged group on NAP-lysine.
(2)

Formation of a colored azo dye.

(approx 5rog)

in

NAP-lysine

was chilled in an ice-bath

and concentrated

(3-4 drops) added.

Chilled 1%

NaNOj solution was then added dropwise until in excess
as indicated by starch-KI paper.

Dropwise addition of

this solution to 2-napthol in 10# NaOH yielded formation
of a red-brown precipitate.
azo dye,

This is presumed to be an

thus implying the presence of a diazotizable

amino group on the starting material.
included

(1)

Negative controls

starting with DNP-lysine and

(2) omitting

NaNO^ solution.
(3) Mass spectroscopy.

The molecular weight of the product

was not successfully established due to technical
difficulties.

Binding of NAP-lysine to anti-DNP antibody.
Anti-DNP antibody was isolated from rabbit immune
sera

(approx Img Ab/ml) by the method of Eisen

Two stock solutions of antibody in 0.1M Tris
were prepared:
dialysis and
quenching.

(a)

(b)

(1964a).

(pH?.6)

0.480mg/ml) for use in equilibrium

0,04?mg/ml for use in fluorescence

Figure 2
Electrophoresis of NAP-lysine

or i g

T”
1l
1
! A
1

o
O
0

o

o

Conditions*

pH 2.3.

acid j

water ::

voltage,
?mamp;
Notation:

! 6
1
1
1
I c
1
11
X_
— — - _ ___ - - - — - _ -

buffer,

formic acid

3»3®1 of 98% soln :

constant at 250v;

time,

glacial acetic

j

29^1

amperage,

:

2000ml;

approx.

90min.

A = DNP-lysine

(starting material)

B = NAP-lysine

(recrystallized)

C = crude reaction mixture
Results and Interpretation.
The product,

NAP-lysine

(B),

contains more

positive charge than the starting material,

DNP-lysine

(A).

If the difference in movement is interpreted as linearly
proportional to charge,
charges.

That is,

then B has twice as many positive

B has two positive charges to A's one.

We presume that the additional positive charge results

Figure 2

(continued)

from the reduction of a nitro group to an amino group.
The crude reaction mixture
(A) and

(C)

contains not only

(B) but also an additional side product which

moves further toward the cathode.

This has an even

greater positive charge and presumably represents
the doubly reduced diaminophenyl compound.

8

Equilibrium dialysis
with micro-dialysis cells
Illinois).
Co.,

(Eisen,

1964b) was performed

(Gateway Immunoserum Co.,

£-2,4-DNP-L-lysine

(New England Nuclear

Mass.) of specific radioactivity 2.57 x lO^^cpm/mole

was a gift of Dr.

R.W.

Rosenstein.

With this a stock

solution of 1 x 10“6m ^H-DNP-lysine in Tris buffer was
prepared.

The dialysis cells used 50jul on each side of

the membrane.
solution.

One side received 5Q**1 of antibody stock

When evaluating the antibody,

the other side

received 5»10»15»25 or 50nl of hapten solution plus
(50-x)nl of buffer.
£-NAP-L-lysine»

When evaluating inhibition by

this side received 10;ul

DNP-lysine solution plus 40nl

(or

35mD

lO”^ or 10“^M NAP-lysine solution.

(or 151*1)
—^

of 10 J%

of
10

-4

,

The cells were

equilibrated overnight and then 25**1 of each side was
counted on a scintillation counter.
The results of these three determinants showed
that the antibody preparation had a K0 of about
3.0 x 106

(M/L)”1 and an r of about 1.1,

even at over 1,000-fold excess,

NAP-lysine,

did not interfere with

DNP-lysine binding.
Fluorescence quenching was done by the method of
Eisen (1964c).

The stock solution of DNP-lysine used

was 1 x 10"^M.

The 3®1 cell was filled with an antibody

solution and the hapten solution added in 10.nl increments.

- 9 -

The results of two determinations give a K0and r for the
antibody preparation in the same range as that noted
above.
The following experiments were performed using
an NAP-lysine solution of 1 x 10"°2M.

(1) NAP-lysine,

in I0;ul increments up to lOCyul

produced only a

total,

slow linear non-specific quenching of fluorescence, not
the sharp initial drop indicative of specific binding.
When DNP-lysine was then added,
curve was obtained.

a classic quenching

The K0and r calculated from this

curve were remarkably consistent with previous results,
despite the presence of 100-fold excess of NAP-lysine.
(2) NAP-lysine and DNP-lysine aliquots were added
alternately to the antibody solution.

Quenching was

observed only when DNP-lysine was added.

There was no

increase or decrease in fluorescence when NAP-lysine was
added.

Thus DNP-lysine caused normal fluorescence

quenching despite the presence of 100-fold excess of
NAP-lysine.
In summary,

there was no evidence that €-NAP-lysine

could bind to anti-DNP antibody.

Affinity labelling

of antibody or immune cells with the diazo-derivative
was not attempted.
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II.

Preparation of a Synthetic Polypeptide Antigen

Materials.
C-DNP-L-lysine HC1 was obtained as above.
NCA-L-t.yrosine and NCA-D,L-alanine
Watertown,

Mass.) were stored in a vacuum desiccator

at -20°C, Absolute ethyl alcohol
dry HC1 gas

(Pilot Chemical Co.,

(Matheson Co Inc.,

,

reagent grade,

and

New Jersey) were used in

the synthesis of £-LNP-L-lysine ethyl ester HC1.

Gel

chromatography was performed with Sephadex G-25 and
G-50

(Pharmacia Fine Chemicals,

(Bio-Rad Laboratories,

Sweden) and Bio-Gel P-2

Calf.).

Rationale and Principles of the Method of Synthesis.
For reasons that will be elaborated in the
discussion,

the antigen desired for this study was:

(D-ala-L-ala-L-ala-L-tyr-B-ala-L-ala-D-ala-L-tyrD-ala-L-ala-D-ala-G-DNP-L-lys)^ q
The procedure of choice for synthesizing the monomeric
subunit is the Merrifield solid-state method

(Merrifield,

1969). However, this method is very time-consuming.
An alternative procedure involves the use of
N-carboxy-oc-amino acid anhydrides
& Sela,

1958).

(NCAs)

(Katchalski

These amino acid derivatives have been

employed extensively to make synthetic polypeptides for

11

immunological studies

(Sela,

1966;

Sela,

1969)*

The

polymerization of NCAs in inert solvents

(e.g. dioxane)

may be initiated by primary amines

amino acid esters

(e.g®

or peptides). Polymerization under these conditions
may be described by an initiation reaction
and a propagation reaction

(Fig.

(Fig.

3a)

Jb),

The occurrence of the initiation reaction formul¬
ated has been demonstrated by the disappearance of the
initiator from the reaction mixture and the simultaneous
appearance of the corresponding amino acid amide during
the early stages of polymerization.
a free ot-amino group and may,
react with available NCA.

The latter contains

therefore,

Dimers,

continue to

trimers and higher

peptides are formed by successive propagation steps
and grow continuously until the reaction ceases because
of either exhaustion of the NCAs or the disappearance
of the terminal amino groups by a termination reaction
(i.e.

side reactions which diminish the number of free

tf-amino groups in the system).

The occurrence of a

propagation reaction of the type given above is supported
by the observation that the polymerization of different
NCAs can be initiated by peptides and by preformed
polyamino acids containing free ot-amino groups.
more,

Further¬

no change in the concentration of free amino groups

occurs in the polymerization devoid of a termination
reaction.

Figure 3

Description of NCA Reactions

(a)

Initiation.

R, R^H

+

/

pH-Co

£

(b)

Propagation.

A
£
—
I
'—|
}
K, £-y (\J- \CO-ClH~ A/ . -CO-CH-fiJH-i.
L
—1 j-1

tl-cP-co N
-p

£

'

pH-CO

/P

£

/OhJ.-CO-CH-PH^
\J

+ c°z.
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In the polymerization scheme proposed above,
growing chains react only with free NCAs and not with
each other.

Therefore in the absence of a termination

reaction, which may usually be neglected at room temp¬
erature,

a narrow Poissonian molecular weight distribution

may be expected.

Thus,

the peptides formed would be

predicted to have a length determined by the starting
ratio of NCAs to initiator, and a composition reflecting
the original mixture of NCAs,

The sequence of amino acid

residues is uncontrolled and should be,
degree,

random

(Katchalski & Sela,

the NCA procedure,

to a considerable

1958),

Thus,

using

a model compound could be synthesized

more easily than the ideal one,

though it would be

less well defined.
The task was to synthesize a peptide approximating
(D,L-ala10,L-tyr2)-£-DNP-L-lys
by using £-DNP-L-lysine as an initiator of an appropriate
mixture of D,L-ala-NCA and L-tyr-NCA.

The most satisfactory

procedure was to synthesize the ethyl ester of
-DNP-L-lysine HC1,

6

neutralize it,

ester free base as the initiator.
procedure is detailed below?
details,

see Appendix.

and use the ethyl
An example

of this

for other systems and further

13
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Synthesis

of

the

Initiator.

£-DNP-L-lysine HC1
in

ethanol

rapidly,

(4ml)

without

dissolved,
ice bath,

-

(200mg»

and

external

cooling.

2 hours).

then sealed and let stand
room temperature.

By

continued to

The reaction mixture was

in a desiccator overnight at

the next day

the reaction had

(Buffer -- butanol:

pyridine::15:3s12:10).

then the solution was

of

The yellow residue was
ether and dried

O.513nimol)

This product
in

50%

ethanol

acetic acid:

excess

recrystallized from

in vacuuo again.

(105mg,

and dried in vacuuo,

The yield

ester HC1 was approximately

(Greenstein & Winitz,

(4ml),

HC1 and

dried in vacuuo over sodium

£-DNP-L-lysine ethyl

(193mg,

thin

Dry nitrogen gas was

passed through to drive off much of the

ethanol and

cooled in an

100% as determined by silica gel

layer chromatography

hydroxide.

suspended

After the amino acid

the introduction of gas

(approx,

gone virtually

was

and a stream of HC1 gas passed through

the hot reaction mixture was

saturation

water:

Q,57nunol)

0.30mmol)

was

1961).
dissolved

neutralized with Na2CC>3
leaving a residue of

90%

(0.15mmol)

£-DNP-L-lysine

ethyl ester free base plus an equimolar amount of NaCl.
The residue was not
separately
dioxane

or mixed.

(3•0ml,plus

soluble in dioxane or THF,
It was
0.5ml),

largely soluble

either

in benzene-

although a noticeable

14
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amount of yellow, almost syrup-like flocculate was
present.

This mixture was used to initiate the poly¬

merization reaction.

Synthesis and Isolation of a Peptide
NCA-D,L-alanine
NCA-L-tyrosine
dioxane

(186mg,

(484mg,

4.2mmol) and

0,9mmol) were dissolved in

(3•0 - 4.0ml).

in dioxane;

(SAM-4).

The NCAs dissolve completely

a cloudy solution indicates some

decomposition to free amino acid.

The NCA solution

and initiator solution were mixed and stirred overnight
at room temperature.

The next day an equal volume

of IN NaOH was added.

The solution now became clear

and was stirred another two hours.
had been shown,
ography,

(?ml)

These conditions

using silica gel thin layer chromat¬

to completely de-estrify

£-DNP-L-lysine ethyl

ester. After two hours the solution was neutralized
(6N HC1) and lypholyzed.
Aliquots

(lOOmg)

of the lypholyzed powder were

dissolved in sodium phosphate buffer

(0.01M,

pH7.4;

4ml).

Insoluble material was separated by centrifugation and
the supernatant chromatographed on G-25 Sephadex
The OD^q an<* °^2?8
measured.
(£=17>400);

The former is the E

(Fig. 4).

^racti°ns were
max

for 6-DNP-L-lysine

the latter is influenced strongly by

■'

Figure 4

SAM-4;

Gel Chromatography Fractionation
OD^q and OD^g

Conditions:

vs_ Tube number

G-25 Sephadex column

with PBS

(2.8cm x 55cm)

(Phosphate Buffered Saline:

Phosphate,

pH7.4,

0.155^ NaCl).

represents 4.9min collection

eluted

0.01M

Each tube

(approximately

5ml).

Results:

By spectroscopic analysis.
Peak

(Tubes)

Average Composition
(B,L-ala:L-tyr:

SAM-4A (32-62)

14 :

3

:

1

-DNP-L-lys)

15

the DNP group
for tyrosine

-

(€=3*000), but is also the isosbestic point
(£=1,350)

(Greenstein & Winitz*

196l).

A

graph of both OD's against fraction number provides an
impression of the variation in the relative amount of
tyrosine per DNP group throughout the gel separation.
That is,

if the two curves are parallel,

a peak is

more likely to represent a homogeneous population of
peptides of relatively constant tyrosine:DNP content
(e.g.

SAM-4,

Fig. 4);

if the two curves are not parallel,

there are likely to be several overlapping populations
of peptides of different composition
Appendix).

Fractions were pooled,

(e.g.

SAM-3,

lypholyzed,

see

desalted

on a Bio-Gel P-2 column, and lypholyzed again. The
product was then either polymerized or used directly for
immunization.
A more precise determination of the average
amino acid composition of an isolated peak was made
by either amino acid analysis or spectrophotometry.
the former,

a small aliquot was dissolved in 6n

boiling) HC1,
to 110°C for

For

(constant

sealed under vacuum in an ampule, heated
16

hours,

in analyzer buffer

dried in vacuuo and dissolved

(0.01N HC1).

The £-DNP-L-lysine

content of an aliquot was determined from the OD^q and
the alanine and tyrosine content from the amino acid
analyzer.

For the spectrophotometric method, an aliquot

- 16

of peptide was diluted in 0.1N NaOH.

The

£-DNP-L-lysine content was determined from the OD^q
Umax»
OD0oo

£=17*^00), and the tyrosine content from
-

(A

contribution

, 6=2,330) after correction for the DNP
(ODg^ ^/OD^q = 0.170).

The alanine content

was estimated by assuming an alaninejtyrosine ratio
equal to that of the Initial reaction mixture.

Synthesis of the Polymer.
The pentachlorophenyl active ester polymerization
method was used

(Kovacs et al,

The peptide monomer

(SAM-4A,

1966;

Richards et al,

196?).

15umol) was dissolved in a

minimum volume of dichloroethanol
excess of pentachlorophenol added.

(0.3ml) and a 1,1 molar
The mixture was

cooled to 0 C and a 1.1 molar excess of triethylamine
and N.N’-dicyclohexylcarbodiimide added.
shaken intermittently at 0°C for 12 hours,
vacuuo at 36 C.

Unfortunately,

It was then
and dried in

chromatography on

Sephadex G-50 and G-25 gave no evidence of polymerization.
There was insufficient time to perform quantitative
dansylation and Edman degradation.

This procedure would

determine the number of N-terminal amines available per
DNP group and thus the degree of polymerization.

The

inability to polymerize the peptide is probably a
result of the low concentration of the reaction solution.

“ I?

Both reports cited above required 1M concentrations of
monomer to achieve polymerization.
yields,

only

0.05M

Because of low

monomer was present in our reaction

mixture.

Immunization and Challenge.
Four to six male and female Hartley strain guinea
pigs, weighing 350 - 400g, were used for each peptide
tested.

Suitable dilutions of peptides

(50Qmg/ml) were

emulsified with an equal volume of complete Freund’s
adjuvant

(Difco Labs,

Inc.,

Michigan).

Each animal

received lOOmg of peptide distributed in the four foot
pads in a volume of 0.1ml per foot pad.

Eight days later,

the guinea pigs were skin tested intradermally in one
flank with lOmg of peptide in 0.1ml of isotonic
saline and in the other flank with lOmg of PPL.
day 10,

they were challenged with

50mg

On

of peptide,

Non-immunized control pigs were similarly challenged
with peptide.

Reactions were read at 4hr and 24hr

following challenge.

Two perpendicular diameters of the

reaction site were measured and averaged.
No immediate reactions were seen.

All immunized

guinea pigs reacted to PPD with more than 10 x 10mm
of erythema and induration, most with more than 14 x 14.
No immunized pigs had more than 4 x 4mm of erythema and
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induration to any peptide tested.

A similar amount of

reaction was seen in the control pigs.

Biopsies of

the challenge site of two immunized pigs revealed only
non-specific polymorphonuclear leukocyte infiltrate
with no mononuclear cells or perivascular cuffing.
list of the peptides used for immunization,
and their composition is given in Table I.

A

their code

Table I.

Peptides Tested for Innnunogenicity

Code Name

Average Composition
(D,L-ala:L-tyr: -DNP-L-lysine)

Approximate
Molecular Weight

SAM-2E

10.8

:

2.3 t

1

1200

SAM-3A

18.2

;

4.0

:

1

2100

SAM-4A

14.0

:

3.0

:

1

1600

(14.0

:

3.0

:

l)?n

SAM-4A-P*

(l600)x(?n)

*

The products of the polymerization procedure were
tested despite lack of evidence that polymerization
was actually achieved.

Discussion
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Receptors:

Some general considerations.

Central to the clonal selection theory of the
immune response is the process by which the immunelogically competent,

precommitted cell can recognize -~

and thus be selected by — specific antigenic determinants.
Such a process must involve structures which interact
with antigens with sufficient energy — bind with
sufficient affinity -- to initiate the cellular activities
that are the immune response.

These "recognition

structures" are clearly crucial to the specificity and
control of the immune system
They are referred to as

(Siskind & Benacerraf,

1969)•

"antigen-binding receptors".

In broad functional terms,

a receptor is the

mechanism by which a signal is perceived and a response
initiated;

it is the process which mediates the afferent

interactions between a "black box" and its environment.
In many biological systems,

such as the immune response,

this function may take the following structural form.
The signal is a small molecule or a particular confor¬
mational determinant of a macromolecule.

The signal¬

binding or recognition site is most likely to be a
cleft or area of a macromolecule.
the

The initial interaction,

"specific" binding of one molecule by another,

may

occur either outside the cell, at the surface membrane,
or inside the cell.

The interaction yields a bimolecular
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complex of

"higher informational content" which may

directly stimulate the cell in a variety of ways,
example, by derepressing a gene,
enzyme,

for

by activating an

or by serving as an enzyme substrate.

Alternatively,

these mechanisms may produce a second intracellular
signal necessary to initiate the cell response.

Thus,

the receptor function may be structurally very complex.
Nevertheless,
(1)

two components can be differentiated --

the specific binding of the signal and

(2)

the

mechanism by which that binding leads to cell activation.
The processes relevant to the non-covalent binding of
two molecules have been carefully studied,

for example,

in enzyme-substrate systems, and it is generally assumed
that similar forces operate in signal-receptor systems.
However,

somewhat greater methodological difficulties are

involved in elucidating the mechanisms and consequences
of molecule-cell interaction.

This is particularly true

in systems such as the immune response, where the
binding structure is believed to function at,
be incorporated into,

and perhaps

the surface membrane of the cell.

In no such systems has the mechanism of receptor function
been clearly established.
This discussion will start with a consideration
of humoral antibody,

for which there is more knowledge

about the relation between the structure and function of
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the

combining site.

specificity

Next,

the focus will be on the

of cell-mediated immunity,

functional property

of

which is a

cell binding of antigen,

then on structural and mechanistic aspects
recognition site.

In this

context,

and

of the

affinity

and synthetic antigens will be considered as

labelling
techniques

for studying both functional and structural characteristics
of

the cell receptor in delayed hypersensitivity.

The Antibody

Response.

Immunization with a classical hapten-protein
conjugate elicits an antibody population which is
tremendously heterogeneous both structurally and
functionally

(Haber,

1967;

Rockey

et al,

1970), A

sub-population with specificity for the hapten can be
demonstrated,
this

and the average

hapten affinity of

fraction increases progressively with

immunization

(Risen & Siskind,

1964).

time after

This maturation

phenomenon has been observed in two species with several
different haptens

(Haber et al,

both from immunological

studies

1967). There is evidence
(Rabat,

1966;

Haber

et al,

1967) and from X-ray crystallography (Poljak

et al,

1972),

approximately

that

the antibody

combining site is

25-44A x 10-17A x 6-10A.

considerably larger volume than is

This

is a

occupied by a simple
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hapten such as

6-DNP-lysine

Several studies

indicate

hapten are important

(Richards

et al,

that determinants

in antibody binding,

serum may also show maturation against

196?).

near the
and that

the larger areas

containing hapten and neighboring determinants
et al,

1966;

Henney,

1970)®

Thus9

antibody population which is

immune

(Parker

there can be an

specific for regions

containing both hapten and protein carrier determinants
and which can bind either hapten alone or protein alone.
Strausbach et al
to be physiologically
that

(1972)

have shown such antibodies

significant.

in both in vivo and

They demonstrated

in vitro systems previously

sensitized to hapten-carrier conjugates,
could elicit a

carrier alone

"signifleant and strong" anti-hapten

secondary response.

The affinities

of antibodies

produced with stimulation either by hapten-carrier
conjugates

or by

carrier alone,

the antibodies produced by

were comparable;

however,

carrier stimulation appeared

to be slightly more heterogeneous

in regard to hapten

binding specificity.
However,

several

important

classes

of

immunogens

elicit antibody with no maturation of binding affinity
and with markedly reduced structural heterogeneity.
class

includes antigens

composed of

immunodominant determinant
relatively

small,

strong,

located in the midst of a

featureless background of rather low

One
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immunogenicity»

For example,

of widely spaced

£-BNP-lysine residues

backbone

(Richards

et al,

the defined sequence polymer

1967;

on a D-L,alanine

Richards

et al,

1969)

elicited antibody whose affinity for 6-DNP-lysine was
initially high

(KA lO^-lO^0)

and remained high,

which demonstrated restricted heterogeneity
One interpretation is
bone apparently
with,

that the bland poly-alanine back¬

and therefore selection of,

tightly

throughout.

contributes minimally to the

antigen elicits

and

interaction

antibody.

Thus

the

only antibody which can bind very

to the sole available immunogenic determinant --

the £-DNP-lysine
Antibody
also evoked by
determinants

"hapten”.

responses
large,

rigidly structured antigenic

of nearly

body combining site.
been reported

of limited heterogeneity are

sufficient size to fill an anti¬
Multiple

examples

(approximate volumes

of

of this have now

the antigen are given
O

where possible);

bradykinin

(Haber et al,

1967);

(Wu & Rockey,

1969)

the

(sphere,

vasopressin
?

folic acid

"loop"-peptide of lysozyme

(DNP)p-gramicidin-S

(Montgomery

(19A x 14a x 11A)
(Rubenstein & Little,

(Maron et al,
et al,

two examples bear closer examination.
of lysozyme is

one

the

intact

1971);

1972).
The

enzyme.

1970);

and

The last

"loop"-peptide

a sequence of 24 amino acids,

on the outer surface of

16a)

diameter

located
It

contains

intrachain disulfide bond which presumably gives

it

-

a relatively constrained
specific

toward this
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configuration.

Antibodies

region were prepared

(1)

by

isol¬

ation from anti-lysozyme antisera with an immunoadsorbent
containing loop-peptide or
immunoadsorbent
peptide

by

isolation on a lysozyme

from anti-sera elicited by

conjugated to a non-immunogenic

polypeptide.

Antibodies

these methods,
compared to

totality

Finally,

drastic decrease
This

unfolding of

the peptide

study provides

of antibodies

show restrictions

resulted in a

reassurance that
includes

directed against
and that

of heterogeneity

in the experimental

It is
site.

in an identical

complementary
Rabbits

sub¬

comparable to that
cited.

of

stable,

symmetry,

conformational

carrying

environment.

to the antibody combining

immunized with this antigen produced

antl-DNP antibody
One

in size

the normal

these sub-populations

situations

cyclic structure with a 2-fold axis

anti¬

structured

(DNP)^-gramicidin-S possesses a rigid,

two DNP groups

chain

in the reactivity with specific

site-filling determinants,

found

prepared by

of anti-lysozyme antibody

response to natural protein antigens
populations

loop-

synthetic

to the loop region,

loop-peptide by various methods,

bodies.

the

showed restricted heterogeneity as

the

population.
of the

(2)

of markedly restricted hetergeneity.

closely studied antiserum displayed a

"monoclonal
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isoelectric spectrum and a heterogeneity
and was

considered

(Montgomery

index of

one"

"biosynthetically homogeneous"

et al,

1972),

Thus a sufficiently

structured

antigen can apparently select and stimulate a single
antibody-producing cell
In summary,

in vivo.

these studies

conceptualization of
First,

clone

support

the following

the humoral antibody

immune response.

although an antibody population may appear to be

quite specific

for a single small determinant

of a larger antigen

(hapten),

(hapten-carrier conjugate),

significant

sub-populations may also have considerable interaction
with adjacent determinants
interactions may be
istics

'(i.e.

crucial

on the carrier).

to the

"classic"

These

character¬

of an anti-hapten antibody response — the

heterogeneity of
maturation of its
determinants

the antibody population
binding affinity.

is

site-filling

uniform affinity.

increasingly pronounced for determinants

greater conformational

In contrast

the specificity

to the antibody response,

specificity of cell-mediated
This gap

is

This
of

rigidity.

Functional aspects of the receptors
cell-mediated immunity.

erized.

Larger,

elicit a restricted sub-population of

antibodies with relatively high,
effect

and the

immunity

of

the

is poorly

charact¬

largely a function of methodological
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limitations®

The product of B cells

from serum by a variety

of procedures and studied and

manipulated with a wide range
protein chemistry.

T cells

of techniques

careful handling to survive.
either by

specificity,

is

The purification of
(T vs B)

1971).

(Miller et al,

Until a few years

effects

ago,

can

the only available assay was

--

recipient

of sensitized cells

either on an immunized animal

however,

of the problem

substantially

(Bloom & Glade,

the

or on the

(adoptive transfer).

relatively recent development of a host of

aspects

they

can

to activation by specific antigens.

skin test

assays has not,

1971s

The state of sensitization

through assay of the

consequent

cell

or by antigen

their specificity and their function,

only be studied
mediate

exudates and require

still a major problem

Wigzell & Andersson,
of T cells,

class

derived from

generally must be obtained

from lymphoid tissue or peritoneal

populations

can be purified

The

iri vitro

improved certain
1971;

Revillard,

1971).
The assays
and reproduce.

themselves are difficult to perform
Different assays are based on different

effects mediated by antigen-activated lymphocytes,
example,
of

inhibition of macrophage migration and

target cells.

Further,

assays measure the total
ation.

It

both in vivo and

for

cytolysis

in vitro

effect of a given cell popul¬

is possible that

sub-populations

of different

I
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composition and
the responses

size mediate different

observed are not proportional to the

number of sensitized cells
antigen.
assays

Thus,

can be

the assays
effect

of

specifically stimulated by

at present,

the results

of the various

compared only semi-quantitatively.

reflect

cell activation which is

of receptor binding of antigen;

directly measure
site"

effects and that

the system.

the

"recognition

which is a structural property

These issues must be

evaluating investigations

the functional

they do not

the relative affinity of

for various antigens,

Finally

considered when

of receptor specificity.

The earliest studies

of the

"immunological

specificity of delayed hypersensitivity reactions
hapten-protein conjugates
contribution of
& Levine,
& Gell,

demonstrated the

the carrier protein

1962;

1959b;

...

...

also Benacerraf & Gell,
Gell & Benacerraf,

"

The phenomenon of

1959a;

1961).

proteins,

This was

were clearly

established.

noted

the antibody

of

soon

carefully

and conjugating procedures.

The simplest in vivo system was used
of sensitized guinea pigs.

Benacerraf

carrier specificity was

examined using a remarkable diversity
selected haptens,

important

(Benacerraf

to contrast with the hapten specificity of
response.

to

— skin testing

The following relationships
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(1)

"Sensitized animals which gave strong delayed
reactions to the immunizing conjugate crossreacted poorly or not at all to (a) conjugates
of the same hapten with a different carrier
protein or (b) conjugates differing from the
immunizing conjugate by having an £-aminocaproyl chain interposed between hapten and
its attachment on the carrier protein. Animals
sensitized with either lightly or heavily
substituted conjugates exhibited strong
delayed reactions to both conjugates, but
more intense reactions to the immunizing
conjugate were always observed" (Benacerraf
& Levine, 1962).

(2)

Animals sensitized to a hapten conjugated
to guinea pig serum albumin showed varying
degrees of cross-reactivity to the same
hapten conjugated to other mammalian serum
albumins.
Such serum albumins are known
to exhibit serological cross-reactivity. The
same hapten on completely unrelated proteins
failed to cross-react, The homologous conjug¬
ate always elicited the largest reaction, while
"the order of the extent of cross-reaction of
the other serum albumin conjugates differed
from one animal to another, possibly owing
to individual variation ... It is also note¬
worthy that the non-ionic hapten p-nitrobenzoyl shows strikingly more carrier-specif¬
icity than the ionic m-azobenzenesulfonate"
(Gell & Silverstein, 1962a).

(3)

"The specificity of the delayed hypersensitivity
reaction is such that it can distinguish the
type
and position_/ of linkage by which a
given hapten is attached to a given protein
carrier. In no instance was a cross-reaction
observed in any of the hapten-protein pairs
among which the only difference was the site
of attachment of hapten on the carrier protein
surface" (Gell & Silverstein, 1962a).

(4)

An elaborate series of substituted azobenzene
conjugates of guinea pig albumin were
prepared, with the benzene ring containing
various ionic and non-ionic groups in different
positions.
There was appreciable cross¬
reactivity between the hapten-protein pairs
among which the only difference was the nature
and/or position of the substituent on the
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benzene ring of the hapten. The degree of crossreactivity was clearly greater than exhibited
by anti-hapten antibody. As always, the
immunizing hapten-carrier conjugate elicited
the maximal response (Silverstein & Gell, 1962b).
Thus delayed hypersensitivity was shown to be not only
"more specific with respect to the total function
determinant, but less specific with respect to the small
haptenic moiety"

(Silverstein & Gell,

1962b).

With the development of in. vitro assays,

the

specificity of cell-mediated immunity to hapten-protein
conjugates has been carefully re-examined
Paul,

1970;

& Pohlit,

Paul & Siskind,

1971)*

The

1970;

Paul,

(Davie &

1970;

Rajewsky

"classic" findings cited above have

been emphatically confirmed and a somewhat more precise
quantification of the degree of cross-reactivity among
the various conjugates has been achieved.

Further,

Francis

and Paul, (1970) have used an in vitro assay to study the
ability of a hapten
activation of
(DNP-GPA).

(€-DNP-L-lysi ne) to inhibit the

sensitized cells by the immunizing conjugate

They concluded:
"Inhibition can be demonstrated only when
exceedingly small antigen concentrations
(10“3ug/ml) and enormous molar ratios of hapten
(lO4*) are used.
These data suggest that cells involved in
cellular immune responses possess receptors
which can interact with haptenic determinants.
The simple interaction of hapten with such
receptors is, however, insufficient to stimulate
such cells so that the specific stimulation
of immunocompetent cells must involve other
requirements".
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Simple,

reversible,

recognition site

structural interaction with the

is clearly insufficient for functional

activation of the receptor mechanism.
Small peptides of known amino acid composition
and sequence,

such as polypeptide hormones,

have also

been used to investigate the specificity of delayed
hypersensitivity.

For example,

the immunogenic capacity

of the AGTH 1-24 peptide appears to reside in the 11-24
fragment,

much of it in the 17-24 octapeptide.

peptides are clearly inactive.
fragments

(eg.

Smaller

Comparison of antigenic

11-24) with non-antigenic ones

(e.g.

1-13)

suggest that immunogenicity is a function of particular
amino acid sequences rather than simply the presence of
particular types of amino acids.

The sequence of the

peptide determines its conformation, which is,
the basis of its immunologic activity

in turn,

(Savin & Liauw,

196?)»

Another study using synthetic Angiotensin II
(an octapeptide) demonstrated a close relationship between
the immunogenicicity of a determinant and its capacity
to elicit a delayed reaction.

That is,

(1)

free angio¬

tensin and angiotensin-protein conjugates were immuno¬
genic and

(2)

in animals immunized with conjugates, both

free angiotensin and heterologous conjugates could
cause delayed reactions

(Dietrich,

1966).

Unfortunately

there is no detailed data on the relation between

pept

DNP'
The

ini
eli

the
pep

Mor1
.

deg
lec
med
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peptide sequence and conformation in these systems.
The specificity of cell-mediated immunity to the
DNP-oligo-lysine system has been exhaustively examined.
The original in vivo studies showed that small nonimmunogenic members of the homologous series of peptides
elicited only antibody-mediated
Larger,

(Arthus) reactions.

immunogenic members elicited both Arthus and

delayed reactions.

In particular,

the upper limit of

the antibody combining site corresponded to the smallest
peptide which was immunogenic

(Schlossman & Levine,

1967)*

More recent in vivo work has demonstrated "the high
degree of specificity possessed by the recognition
mechanism associated with the lymphoid cells which
mediate cellular immune responses"

(Paul et al,

1971).

In particular,
"the sensitized cell is maximally stimulated
by the homologous immunizing antigen and can
discriminate among components which differ from
one another only in the position of a
dinitrophenyl group or D-lysine residue on
an identical oligo-lysine backbone ... /it
appears that/ the majority of cells produced
as a consequence of immunization have stereo¬
specific antigen receptors for the DNPoligo-lysine / i.e. the hapten-carrier
conjugate_J used to induce the response; a
smaller and more variably-sized population
of cells is produced with receptors specific
for the oligo-lysine portion / i.e. carrierJ
of the immunizing antigen" (Schlossman et al, 1969).
One of these studies found an imperfect correlation
between the in vivo skin test and the in vitro assay.
In particular,

the assays indicated reactivity to some

ant:

pat-
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antigens which had given negative skin tests.

The

pattern of these responses suggested the existence of
a smaller, purely carrier-specific cell population,
as mentioned above.
that

The investigators commented only

"these observations suggest that the in vitro

response as measured by thymidine incorporation is
either a more sensitive assay,

or alternatively, not a

simple in vitro correlate of delayed hypersensitivity"
(Schlossman et al,

1969).

The studies considered thus far have focused on
the specificity of delayed hypersensitivity at a given
point in the immune response.
issue of whether, with time,

There remains the important
delayed hypersensitivity

exhibits a maturation of affinity and broadening of
specificity analogous to the changes seen in the antibody
response.

The direct in vivo system is not well suited

to approaching this question.

The onset of antibody

production causes the appearance of
sensitivity"

"immediate hyper¬

(the Arthus reaction) at the site of an

intradermal challenge.

As expected,

this reaction is

hapten-specific and it generally extends from about
1 to 6 hours after the challenge.
complicates, at the very least,

the reading and inter¬

pretation of the delayed reaction.
studies,

Its appearance

In most in vivo

skin testing was performed 7-10 days after
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immunization,

at which time delayed hypersensitivity

can be demonstrated but there is generally no Arthus
reaction.

This procedure avoids the problem but,

unfortunately,

begs the question.

One investigation of this issue used the adoptive
transfer system
indicated that

(Phair & Kantor,

1968),

This work

’’the ability of donor cells to transfer

delayed hypersensitivity persisted throughout the
primary and secondary antibody responses of the donor
animals.

The skin reactions elicited in recipients of

cells from hyperimmunized guinea pigs remained conjugatespecific throughout the immune response".
Several studies have attempted to evaluate
directly the course of the delayed hypersensitivity
response in an actively sensitized animal
Kruger et al,

1971).

(Henney,

1970;

These studies appear to indicate

that after 2-3 weeks a hapten-specific component of
the delayed reaction can be identified.

This component

was accented by challenge with higher doses of hapten
on a heterologous carrier.

In all cases the simultaneous

presence of hapten-specific antibody was documented either
by the Arthus reactions or serum
However,

binding activity.

the conclusions reached in these studies

have been challenged.

Using passively and actively

immunized guinea pigs,

Phair and Kantor

(1970)

studied
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the

interaction of

sensitized cells,

challenge antigen at various

immune

serum and

concentrations.

Hapten-

specific delayed reactions were produced in the recipients
of sensitized cells by

(1)

challenge with a high concentr¬

ation of hapten conjugated to heterologous
protein;
serum;

(2)

(3)

simultaneous

transfer of hyperimmune

challenge at the site

immediate reaction.

carrier

In actively

of an unrelated
immunized guinea pigs,

hapten-specific reactions were facilitated by preparation
of the

challenge

serum,

or unrelated immediate reactions.

ators

site with anti-hapten antibody,
The

normal

investig¬

considered that two mechanisms might underlie such

hapten-specific delayed reactions;
"

(1) increased retention of antigen at the
skin site secondary to antigen-antibody
interaction and consequent stimulation of
those cells capable of responding to an
increased concentration of hapten; (2) a
non-specific increase in the number of
mononuclear cells at the reaction site,
thereby increasing the probability of
interaction of antigen and cells with a
high affinity for the haptenic group"
(Phair & Kantor, 1970).

The question of

"maturation"

of the specificity

of delayed hypersensitivity has also been examined using
an in vitro assay
obtained will be

(Henney & Nordin,
considered

1971).

in some detail,

The results
for they

highlight both the potential and the problems
vitro methodologies

(Table II).

of

in

The data for effector

Table II

Specificity of cytotoxic lymphocyte population from
guinea pig spleen following immunization with
DNP-HGG

Time after
Immunization

^Specific -^Cr Release3, from Mastocytoma cells Coupled with:
DNP-HGG

DNP-BSA

HGG

4

4.1

0

0

7

13.5

4.5

7.1

14

31.3

20.0

28.6

21

19.9

15.9

17.6

28

18.7

10.1

15.9

days

Or

SI

Cr release in the presence of lymphocytes
from specifically immunized animals minus the
release obtained in the presence of lymphocytes
from unimmunized controls.

1
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cell activation by the immunizing conjugate confirm
previous expectations.

The authors comment that it was

"rather unexpected" to find
"that ’target’ cells bearing only the carrier
portion of the immunizing conjugate were lysed
as effectively as those bearing the whole
conjugate".
They used the macrophage migration inhibition test
to provide additional evidence.

Those results reassured

them

it is quite clear that

(Table III),

Nevertheless,

the two assays give quantitatively different anwers,
Moreover,

although the workers make no comment on it,

the degree of
lysis on d.l4j

"hapten-specific" lysis
80$ on d.2l)

quite startling.
uncertain.

First,

(64$

of conjugate

is not only unexpected,

but

The cause of these anomalies is
the stimulus is very complex.

Random

light conjugation of a population of carriers could
easily produce overlapping sub-populations containing
(l)

each major carrier determinant intact and

hapten in a wide variety of environments,

(2)

the

Further,

the

in vitro assays probably are more sensitive than the
in vivo test and can more readily detect small populations
of cells responsive to pure carrier determinants or
hapten-focused cross-reacting determinants.
also probably
addition,

There are

"non-specific recruitment" effects.

In

a variety of cell types are present in the

lymphocyte pool assayed.

For instance,

the authors

Table III

A comparison between the specificity of the humoral
and cell-mediated immune response of guinea pigs
14 days following immunization with dinitrophenylated human IgG

DNP-HGG

% cytol,ysisa

31.3

DNP-BSA

HGG

20.0

28 o 6

24 - 4.8

41 ± 2.8

% inhibition of
macrophage migration*3
PFC/106 splenic
lymphocytes0

60 - 2.2

930

789

a ^specific
release as per Table II
10 The percent inhibition of the migration of
peritoneal exudate cells from unimmunized
guinea pigs in the presence of lymphocytes,
from animals immunized with DNP-HGG, and
300g/ml antigen.
The values given are
- standard error of the mean of nine
determinants on a pooled lymphocyte
preparation from three spleens.
c Total ("direct” and "indirect") plaques per
10° splenic lymphocytes using antigen-coated
SRC.

6
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clearly document cells producing hapten- and carrierspecific antibody,
this might have.

but do not control for any effect
It must be stressed that this study

is one of the most careful and precise available,*

it is

the state of the art that wants improving.
One well-investigated system does seem to exhibit
hapten-sepcific delayed hypersensitivity -- p-azobenzene-

I

arsonate

(pABA) derivatives of tyrosine

Leskowitz et al,

1966).

(Leskowitz,

1963;

Studies with these derivatives

emphasise the relationship between the immunogenicity
of a given molecular configuration and its capacity
to evoke a delayed reaction.

Animals immunized with

pABA-N-acetyl-L-tyrosine amide
weight, 450),

(pA3A-tyr;

molecular

the smallest known Independent immunogen,

will produce characteristic in vivo delayed reactions
to homologous or heterologous conjugates of pABA
(Leskowitz et al,
In vitro,

1966;

Borek,

Stupp & Sela,

their lymphocytes can be activated by pABA-tyr

or a protein conjugate with equal efficiency
& Raynaud,

1965)®

1971).

Further,

{Nauciel

the immunogenicity of a

variety of non- or weakly-immunogenic proteins and
synthetic polypeptides is notably increased by
with pABA.

conjugation

This change is accompanied by the development

of hapten-specific delayed sensitivity,(Jones & Leskowitz,
1965;

Borek & Stupp,

1965;

Stupp,

Borek & Sela,

1966).
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Of the azophenyl acids,
phosphanilic acid

only conjugates of

(pABP) share this immunologic property;

conjugates of aminobenzoic

(pAB)

or sulfanilic

acids clearly do not,(Leskowitz & Zak,
& Stupp,

1965).

1966;

(pABS)

Borek

Substituted derivatives of pABA and

pABP conjugates have been used to compare the cross reactivity of hapten-specific delayed sensitivity with
that of hapten-specific antibody.
interpreted as indicating that,

The results were

in this system at least,

"recognition sites for delayed sensitivity are very
similar to those for antibody"
Nevertheless,

(Leskowitz,

196?).

the mechanism of hapten-specific delayed

hypersensitivity remains unclear.

The simplest hypothesis

is that this particular configuration of polar and
hydrophobic groups can by itself provide sufficient
interaction to activate the necessary and appropriate
cells.

That is,

unlike other haptens,

this moiety does

not require the additional energy contribution of
adjacent carrier determinants,

Structural Aspects of the Receptor.
The work reviewed to this point has concerned the
specificity of delayed hypersensitivity and,

therefore,

the functional characteristics of the antigen receptors
involved.
clarify

There has also been a considerable effort to
the structural characteristics of T cell
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receptors.

Here too,

logical problems.

there are a variety of methodo¬

The

lymphocyte populations most

easily obtained contain more B cells than T cells.
Moreover,

B cells appear to bind much more antigen to

their surface,

and more readily.

Therefore,

techniques

are required which specifically detect T cells or
provide T cell enriched populations

(Miller et al,

1971).

Much of the work available is very recent and either
unconfirmed or challenged.

This survey will focus on

those generalizations that seem most broadly supported.
Multiple lines of evidence suggest that T cells
do have specific antigen binding receptors:
specific activation of T cells by antigen;

(1)
(2)

the
specific

inactivation of T cells by 125i_xabelled antigen
induced cell

"suicide’');

(3)

the capacity of T cells to

carry memory and to be made tolerant
1970;

Dwyer & Mackay,

1971;

(antigen

(reviewed by Moller,

Miller et al,

1971).

It has

been somewhat difficult to establish conclusively that
there are antigen-binding structures actually on the
cell surface.

T cells seem to have far fewer such

structures than B cells
1971;

Unanue et al,

(Raff,

1971;

1970;

Rabellino et al,

Greaves & Hogg,

1971).

The

estimate is that there are in the order of 500 receptors
on the surface of a T cell, but 50,000 - 150,000 on a
B cell

(Marchalonis et al,

1972).
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Evidence is accumulating that the recognition
structure is an immunoglobulins

(1) Anti-light-chain

antisera has been reported to inhibit the ability of
lymphocytes to effect the graft vs host reaction of the
transfer of delayed hypersensitivity
Mason & Warner,

1970);

(Greaves et al,

1969;

(2) anti-kappa antisera has been

shown to protect T cells against ^^I-antigen "suicide"
(Basten et al,

1971);

(3) anti-Fab and anti-light-chain

antisera can inhibit T-rosette forming cells
Hogg,

(Greaves &

1971).
The class of heavy chian is a matter of considerable

debate.

Many studies have found no evidence for any of

the currently known class of heavy chain
Greaves & Hogg,
Hogg

1971).

(reviewed by

Recent data from Greaves and

(1971) suggest that there are ju chains on T cells

but perhaps only partially exposed.

They support the

interpretation that the differences between antigen
receptors on T and B cells are both

(1) quantitative,

T cells having far fewer receptors,

as noted above,

and

(2) qualitative,

T cell receptors being

"buried in

the plasma membrane in such a way that only the variable
region (containing the combining site)
Furthermore,

is exposed".

speculating from studies of cells before

and after challenge,

they constructed a model of matur-

ational changes in the relationship between the receptor

.
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and the cell surface membrane.

In particular,

hypothesized increased exposure of the heavy
after immunization.

they

(ji)

chains

Other evidence for m chains in the

receptor is based on the claim that immunoglobulin
isolated from the surface of T cells contains heavy
chain which resembled ;u--chain in electrophoretic
behavior

(Marchalonis et al,

1972),

are unconfirmed and involve new,
they are,

therefore,

Both these studies

specialized techniques;

difficult to analyze critically at

this time.
It must be stressed that the evidence associating
the immunoglobulin detected on the cell surface with the
putative receptor is subject to several important
limitations.

First,

there is no unequivocal evidence

that the cell has synthesized the immunoglobulin.

However,

there have been several attempts to coat lymphoid cells
with "exogenous" antibody using a variety of in vivo
and in vitro conditions and none have produced any
significant passive absorption

(Greaves,

1971).

Second,

the inhibition of receptor function by anti-light-chain
or anti-Fab antisera may result from

(a)

the receptor

site actually containing the immunoglobulin determinant
or

(b)

the receptor site being in closer proximity to

the determinant and the binding of antisera interfering
with the receptor by steric hindrance.

Moreover,

the
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techniques currently stressed cannot clarify antigen¬
binding specificities and affinities of the recognition
site nor elucidate the mechanism by which antigen-binding
activates the cell.

Some Hypotheses about the Receptor.
Extrapolating from the wide variety of data that
has been presented,

it is possible to formulate several

hypotheses about the antigen-binding structure of cellmediated immunity.

This may facilitate considering

methods for further study.

(For convenience,

"receptor"

will be used when referring to the antigen-binding
structure,

which is the first component of the functional

receptor).
(1)

The receptor is an immunoglobulin.

This will only be established when the receptor is
actually isolated.

The class of heavy chain is of little

concern for this model.

It would not,

surprising if a new class were found.

however, be
The Fc region of

a cell-associated receptor could reasonably have a different
structure for its special function.
(2)

The receptor site is the same size as an immunoglobulin

combining site.
(3)

An "effective determinant" is one which can specifically

elicit a cell-mediated immune reaction.

It is generally
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about the size of the receptor site.
As has been seen,

the volume of the combining site is

considerably larger than most simple haptens and can
encompass significant portions of most of the globular
proteins commonly used as carriers.
systems shows that

(a)

Data from several

the minimum size for an immunogen

is approximately the upper limit of the antibody combining
site and

(b) the requirements

(including size)

for

immunogenicity are closely related to those for eliciting
a delayed reaction.

Further,

there is evidence that

an antibody combining site may have several
regions" each with a different
et al,

1972).

Presumably,

"contact

"specificity"

therefore,

(Rosenstein

a site-filling

antigen would bind to the site at more than one point.
As a result of such multiple contacts,
expected that

(a)

the affinity of the site for the antigen

would be relatively great

(in the antibody systems consid-

ered above K0's of about 10
found),

it might be

6

9
-1
to 107(M/L)

(b) altering any single determinant

are generally
(eg.hapten)

would not greatly affect the overall interaction of the
antigen and the site unless marked steric hindrance
was introduced and

(c)

the relative configuration of the

various contact determinants

(i.e.

the structure of the

antigen) would be of central importance to the overall
interaction.

These characteristics anticipated of a site¬

filling determinant are congruent with the phenomena of

0
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carrier specificity.
(4)

As carrier specificity is both sufficient and

necessary in cell-mediated immunity,

such site¬

filling is a requirement for activation of the cell.
One can only speculate about the mechanism of such a
receptor.

It might reasonably be offered that the inter¬

action of antigen and receptor causes a conformational
change in the receptor which leads to cell activation.
Metzger

(1970) has reviewed the work that might provide

data to support such a suggestion.

He concluded:

"So far, no convincing evidence is at hand
which demonstrates that reactions at the
combining sites of antibody produce defined
conformational changes elsewhere in the
molecule".
It could be argued that the environment of the cell
receptor facilitated changes not noticeable in other
contexts.

Moreover,

the systems studied have primarily

involved either highly heterogeneous antibody populations
against a hapten-protein conjugate,
with anti-hapten binding activity

or myeloma proteins

(Ashman et al,

1971).

The next logical system to examine would seem to be the
structured site-filling antigens which elicit antibody
populations of restricted heterogeneity.
The model suggests an explanation for why some
"structure" — a "preferred conformation" — seems to
be a requirement for immunogenicity.

The process of

inducing a conformational change in the receptor requires
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energy.
energy
of

One source for this
inherent

energy might be the potential

in a preferred structural

the antigenic determinant.

rigidity,

However,

This may

stimulated

in some animals,

Exceptions
hypothesis

only one

of

the

clone was

and apparently none in others.

site-filling structured antigen

can be accommodated by

they can satisfy

for energy
the

to the

into fewer

explain such situations as

(DNP)2“gramicidin-S system where

that

with increasing

the antigen could presumably fit

receptor sites.

configuration

the model by presuming

in other ways

the

requirements

interaction with the receptor.

For example,

"hapten-specific" delayed hypersensitivity of the

pABA system may represent a situation where an ordered
arrangement

of strong polar and hydrophobic groups

can

interact sufficiently with particular points around the
receptor combining site

to cause activation.

it

this model

should be noted that

apply

equally

to the

interactions

antibody-producing cells.

While

intended to

of antigens and
there is

these hypotheses might be relevant
that system,

is not

Finally,

evidence that

to some aspects

of

different mechanisms may operate in

other aspects.

Methods

for the Study

of the Receptor.

More direct and controlled methods are required
to

characterize further the structure and function of

the

-

receptor and,
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ultimately,

-

to isolate it from the cell.

"Affinity labelling" is a technique which has been very
successfully used in the study of the antibody combining
site

(Singer & Doolittle,

1966;

Singer,

1967).

The method

depends upon the ability of a bifunctional reagent to
(l)

combine specifically with the particular anti¬

body and

(2) react readily with amino acid residues to

form covalent bonds.

The successful labelling of the

receptor recognition site should block the ability of
the cell to respond to antigen.

This functional effect

could be evaluated with an in vitro assay or an adoptive
transfer.

Necessary controls would include

(l) persistence

of sensitivity to an unrelated antigen to evaluate non¬
specific toxic effects of the procedure and

(2)

"cross¬

over" experiments using labels derived from two unrelated
determinants to evaluate effects due to possible differ¬
ences in the numbers and types of sensitized cells elicited
by different antigens.

Further,

a radioactive tag on

the affinity label would permit the use of autoradiography
to localize the site of the receptor, and would provide
a means of tracing the labelled recognition structure
through physico-chemical procedures leading to its
isolation and structural characterization.

In these

experiments it would be necessary to evaluate the
specificity with which the label attached to the receptor
as opposed to elsewhere on the cell.

This might be done
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by protection and differential
(Singer,

labelling techniques

196?).

Affinity labelling

of receptors

on antibody-

producing cells has been attempted and is
problems,

Plotz

(1969)

and Segal

et al

(1969)

ently reported

the specific

using affinity

labels derived from hapten.

often cited,

inhibition of antibody response

Naor et al

(1970)

reaction of the
concluded that

tiny

This work is

demonstrated that such

systems are plagued by many effects

the

not related to the

label with the receptor.
the percentage of

Moreover,

specifically

in a normal lymphocyte population was

fraction of
that

ations

independ¬

but not confirmed and apparently not

reproducible,

cells

fraught with

they

sensitized

so small and

specific receptor to cell membrane so

"the cumulative level of nonspecific modific¬

in the

system almost

specific approaches

to

certainly would nullify

isolating few affinity labelled

receptors".
In cellular immune

systems,

affinity labelling are compounded,
unsuccessful

in attempts

the difficulties
Kantor

of

(1969) was

to use Segal's affinity labels

to block the transfer of delayed hypersensitivity even
though the treated cells were heavily
contrast,

Hill

(1971)

conjugated.

In

claimed that an affinity label

derived from the same hapten could block an adoptive
transfer and could permit
receptor.

the

isolation of a putative

-
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The immunizing agent Hill used was
dinitrobenzene

(FDNB)

(I

in Fig.

react with the free amino groups
proteins
lysine)

1),

l-Fluoro-2»4-

which is known to

of lysines

of skin

to yield £ -2,4-d.lnitrophenyl lysine
residues

(II).

autologous proteins

It

is

probably by

that FDNB causes

(£-DNP-

thus altering

contact sensitivity.

Sensitization with FDNB or DNP-protein conjugates also
effectively
sites

of

elicits anti-DNP antibodies.

The binding

these antibodies have been extensively

igated with a series

of affinity labels,

the most success¬

ful being m-nitrobenzenediazonium fluoroborate
(III)

(Good,
Hill

affinity

Traylor & Singer,

label which would

196?).

"resemble
He reports

£-2-nitro-4-aminophenyl lysine

the DNP-protein
the synthesis

(6-NAP-lysine)

conversion to £-2-nitro-4-diazophenyl

lysine).

(MNBDF)

sought to derive from 6-DNP-lysine a new

conjugate more closely".

its

invest¬

He further claims

anti-DNP antibody by
by £-NAP-lysine and

of

(IV)

lysine

and

(6-NDP-

that the precipitation of

DNP-albumin was blocked reversibly
irreversibly by the affinity label.

No data is presented to support these assertions.

Previous

investigation of hapten-antibody binding in the DNP
system seemed to indicate that reduction of a nitro
group,

particularly

the

"lead" or

"4" group,

significantly lower the affinity of the
for the altered hapten

would

combining site

(Pressman & Grossberg,

1968),

-

Our attempts

to reproduce Hill's work strongly indicated

that this was
of
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the case and,

cells with this

threfore,

system was

not attempted.

The work of Francis and Paul
Kantor

(1969)

suggests

affinity labelling

(1971)

and of

that most hapten-derived affinity

labels will be ineffective because of

insufficient

ability

Rather,

to localize at the receptor.

an affinity

label for the recognition site of delayed hypersensitivity
should be based on an

"effective determinant".

icular,

it would be desirable

to have a small,

readily

synthesized determinant

immunogenic

fragments,

DNP-oligo-lysines,

or pARA derivatives.

on an alanine backbone

possibilities

hormone peptide

Another model might be

the defined sequence antigen of widely
lysines

defined,

to which the reactive

labelling group could be easily attached;
include

In part¬

spaced £-DNP-

(Richards

et al,

196?).

This polypeptide readily

elicited the production of anti-

DNP antibody

but would not

in rabbits,

hypersensitivity

in guinea pigs

are many advantages
type as

respect

Those discussed by

In addition,

could be readily made for use
of

the receptor

There
this

Richards

et al
With

the monomer or a similar

the peptide might serve as

affinity label.

196?).

homogeneity and conformation.

to the current issue,

sub-unit of

(Leskowitz,

to using a peptide polymer of

an immunogen.

include simplicity,

elicit delayed

the basis

for an

controlled variations
in studying the specificity

(as per Parker et al,

1966).

I

-
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The task thus became to establish the minimal
modification necessary to make the above peptide
immunogenic to guinea pigs.

The requirements for immune-

genicity of synthetic peptide antigens in terms of
complexity of amino acid composition and sequence have
been partially but not systematically studied
Borek,

1968;

Rude,

1970).

(Sela,

1966;

On the basis of available

reports it was felt that the addition of approximately
two tyrosine residues among the ten alanine residues
might be sufficient.
adding tyrosine —

There were also advantages to

(1) it could serve as the point of

attachment of other haptenic groups,
azophenyl acids;

(2)

in particular,

the

it could be radioactively tagged

at very high specific activity with ^5i for a variety
of studies.

Unfortunately the synthesis of the desired

polymer was not achieved due to time limitations and,
therefore,

no definite conclusions about its immuno-

genicity can be made.

As detailed above,

the monomeric

units which were synthesized were non-immunogenic.

Summary.
Cell-mediated immunity encompasses many immuno¬
logical phenomena including homograft and tumor
rejection.

The operative immunocompetent cells appear

to be stimulated by the specific interaction of
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antigen with surface membrane associated receptors.
Evidence

concerning the functional and structural

characteristics
Further study of

of

these receptors has been reviewed.

them through an affinity label based

on a defined peptide antigen has been considered.
molecular mechanism of
immune cells

The

the specific activation of

is at present unclear,

and a variety of

methodological approaches will be necessary
our understanding of antigen receptors.

to further

Appendix

-

Details
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of Peptide Synthesis.

Four different procedures were used in the attempt
to synthesize the desired peptide.

The conditions which

were varied included the initiator,

the solvent for

the initiator,

the amounts

The products were

coded as

Synthetic Antigen Model
Table AI
procedures.

compares

Figures Al,

chromatographic

of NCAs and
follows;

the reaction time.

SAM-4A means

-• procedure #4 ~ peak A.
the

conditions

of

the various

A2 and A3 show the gel

separation of

the products

of reaction

and give the average peptide composition for the
analy z ed p eaks ,
Several observations may be made relating
various
First,

reaction conditions with

the products

the

obtained.

initiation with £-DNP-L-lysine HC1 gave a very

heterogeneous

collection of products

relatively well dissolved.
the tendency of

even when it was

We assumed that this

the initiator amine

reflected

to be protonated.

Since only the free base can initiate NCA polymerization,
different subsets

of

NCAs at different

times.

populations

the initiator pool activated the
This

led to the formation of

of different size peptides as

the multiple peaks.

Thus,

reflected in

it appeared necessary

an initiator with an unproponated amino group.

It

to prepare
should

be noted that although SAM-2E had the desired composition,

-

its yield was
so

52

so small and

improbable that

-

its homogeneity seemed

the procedure was

Initiation with the free base
much more
peaks

satisfactory.

not acceptable.
ethyl

Procedure 3

ester was

contained anomolous

of high tyrosine:DNP content because of

errors

in preparing the NCA reaction mixture.

technical
These led

to the premature decomposition of some NCA-tyrosine and
thus

the presence of peptides

instead of DNP-lysine.
Virtually all

initiated by

Procedure 4 was

the product was

found

tyrosine

almost

ideal.

in a single,

large,

apparently homogeneous peak whose composition closely
reflected that of

the starting materials.

The few small

trailing peaks presumably reflect delayed initiation
by

the

initially

some additional

insoluble portion of
experimentation,

steps,

By thus

With

conditions might be

found which give a reaction product
sition,

initiator.

of uniform compo¬

eliminating the multiple purification

sufficiently high yields might be obtained to

achieve successful polymerization of

the peptide.
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Figure A1

SAM-1

s

Gel Chromatography Fractionation

0^360

Conditions:

Results

— Tube number

P-2 Bio Gel column

(2.5cm x 77cm)

with PBS.

Each tube represents 9»9niin

collection

(approximately 4.6ml).

:

eluted

By amino acid analyzer

Peak

(Tubes)

Average Composition
(D,L-ala:L-tyr:6-DNP-L-lys)

SAM-1A

(61-70)

2.7

J

1

:

1

Figure A2

SAM-2

:

Gel Chromatography Fractionation
OD^q vs. Tube number

Conditions

Results

:

:

as for SAM-1

By amino acid analyzer

Peak

(Tubes)

Average Composition
(D,L-ala:L-tyri£-DNP-L-lys)

SAM-2A (29-31)

43

SAM-2E (53-60)

10.8

:

4.8
:

2.3

:

1
:

1

^rz>Oj

?vpru

Figure A3

SAM-3

J

Gel Chromatography Fractionation
OD360 and- ^^278 —

Conditions

Results

:

Peak

num^er

: as for SAM-4

By spectrophotometric analysis

(Tubes)

Average Composition
(D,L-ala:L-tyr:£-DNP-L-lys)

SAM-3A (41-66)

17.4 :

4 :

1

0
—S)
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